Literature DB >> 9434279

Understanding how elderly patients process drug information: a test of a theory of information processing.

T P Christensen1, F J Ascione, R P Bagozzi.   

Abstract

PURPOSE: The goal of this research was to apply a well-known model of consumer behavior, the Elaboration Likelihood Model (ELM), to "direct-to-consumer" advertising of prescription drugs aimed at elderly consumers. In particular, the specific aim was to determine whether the effect of promotional aspects of consumer drug advertising predicted by the ELM could by demonstrated on elderly consumers' product attitudes and perceptions of risk.
METHODS: Subject reaction to a fictitious drug advertisement was assessed using a 2 x 2 x 2 factorial design based on the theoretical concepts of the ELM. the advertisement message varied in the expertise of the product endorser, the expected involvement or interest level of the study subject, and the content of the advertisement message.
RESULTS: Analysis of variance revealed a three-way interaction effect between involvement, argument quality, and source credibility on subjects' attitudes toward the product [F(1, 123) = 4.77, p = 0.03] and perceptions of risk [F(1, 118) = 3.22, p = 0.08]. The information content of the ads had an impact on subject's attitudes under the low involvement/low credibility condition but not the low involvement/high credibility condition. Under high involvement conditions, the information content of the ad impacted attitudes under both the high and low credibility conditions.
CONCLUSIONS: It appears that the ELM may be a useful model for determining when elderly individuals are more likely to be influenced by the information content or the promotional aspects of consumer advertisements for prescription drugs.

Entities:  

Mesh:

Year:  1997        PMID: 9434279     DOI: 10.1023/a:1012182419037

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  5 in total

1.  The patient package insert--an ethical dilemma.

Authors:  C L Braucher
Journal:  Am J Pharm Educ       Date:  1981-02       Impact factor: 2.047

2.  Direct to consumer advertising of prescription drugs. FDA's first round of tests.

Authors:  D H Murphy
Journal:  Am Pharm       Date:  1984-02

3.  Matching prescription drugs and consumers. The benefits of direct advertising.

Authors:  A Masson; P H Rubin
Journal:  N Engl J Med       Date:  1985-08-22       Impact factor: 91.245

4.  The relative impact of age and attractiveness stereotypes on persuasion.

Authors:  J M Puckett; R E Petty; J T Cacioppo; D L Fischer
Journal:  J Gerontol       Date:  1983-05

Review 5.  Nonsteroidal anti-inflammatory drug toxicity: increased risk in the elderly.

Authors:  M E Weinblatt
Journal:  Scand J Rheumatol Suppl       Date:  1991
  5 in total
  1 in total

1.  What kind of patients and physicians value direct-to-consumer advertising of prescription drugs.

Authors:  F F Gönül; F Carter; J Wind
Journal:  Health Care Manag Sci       Date:  2000-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.